J. Dotterweich

发表

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma

P. Trerotoli, A. Rosenwald, H. Einsele, 2017, Leukemia.

Site-specific conjugation of native antibodies using engineered microbial transglutaminases.

S. Hecht, J. Dotterweich, C. Schroeter, 2020, Bioconjugate chemistry.

Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells -Implications for myeloma bone disease.

A. Keller, F. Jakob, D. Schneider, 2016, Bone.

Heparin affects human bone marrow stromal cell fate: Promoting osteogenic and reducing adipogenic differentiation and conversion.

F. Jakob, J. Dotterweich, N. Schütze, 2015, Bone.

The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease

L. Hofbauer, C. Glüer, F. Jakob, 2016, PloS one.

Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells

F. Jakob, J. Dotterweich, R. Ebert, 2014, Cell Communication and Signaling.

Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose‐ and time‐dependent manner

H. Einsele, J. Dotterweich, J. Lohmeyer, 2018, Clinical and experimental immunology.

Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells

F. Jakob, J. Dotterweich, R. Ebert, 2014, Cell Communication and Signaling.

Small molecule enhancers of rapamycin induce apoptosis in myeloma cells via GSK3A/B preferentially within a protective bone marrow microenvironment

H. Einsele, J. Dotterweich, G. Stuhler, 2014, British journal of haematology.